Krystal Biotech Inc (KRYS)

SG&A Expense Growth

-2.84%

Quarterly · Period ending:

KRYS logo

KRYS SG&A Expense Growth

Latest reported-2.84%
KRYS Quarterly SG&A Growth (QoQ) (0.00% → -2.84%)
High-resolution chart · PNG

KRYS sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-2.8381%
-0.6444%
9.8515%
6.8771%
7.4474%
4.5864%
8.9681%
3.9347%
6.0173%
12.0437%
-1.8568%
-8.5199%
7.7762%
0.0208%
20.5418%
11.5994%
16.3334%
19.3363%
34.4233%
-2.3166%
20.2036%
71.6933%
3.6681%
38.1599%
36.9269%
34.1274%
23.8847%
-12.963%
9.6267%
7.7629%
33.9319%
14.5022%
22.0608%
84.6341%
-44.4444%
174.3494%
84.2466%
-33.0275%
169.1358%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.